Healthcare institutions and community organisations across Saudi Arabia are expanding efforts to combat diabetes through public education, early detection, and digital disease management tools.
The initiatives place strong emphasis on modern medical technology to track and treat the condition. The Kingdom launched the Diabetes Command and Control Center in 2025 to digitally monitor health indicators across regions, facilitating early medical intervention and strengthening communication between doctors and patients.
Health clusters have also widened the distribution of continuous glucose monitors and modern insulin pumps, including wireless models. In November 2025, the Health Endowment Fund introduced a program providing insulin pumps to children diagnosed with Type 1 diabetes, with an initial target of assisting 600 children annually to improve blood sugar control and reduce the treatment burden on families.
Local outreach efforts are simultaneously targeting educational communities. The General Department of Education in Makkah Region recently collaborated with the Makkah Health Cluster and two nonprofit healthcare groups to run an awareness campaign at the department's headquarters for World Diabetes Day.
The Makkah event provided attendees with glycated hemoglobin (HbA1c) tests, medical consultations, preventive health guidance, and blood glucose monitoring units. Officials aim to use such partnerships between education and health sectors to encourage healthier habits and curb long-term complications.
Medical specialists highlight regular physical activity as a core component of diabetes management, noting that exercise enhances insulin sensitivity, regulates blood sugar, and supports cardiovascular health. For children with Type 1 diabetes, experts advise that exercise must be balanced with continued insulin therapy, proper nutrition, and routine glucose checks under professional medical supervision.
The national measures coincide with broader global research into improved diabetes treatments, including automated systems linking sensors to insulin pumps, new drugs for Type 2 diabetes, and experimental therapies using insulin-producing cells that are still being evaluated for long-term safety.